Biotech Connection Singapore 77 posts 0 comments

Healthcare Connection Night in Singapore, hosted by KPMG and co-organized by Biotech Connection Singapore (BCS) and Singapore Healthcare Drinks (HCD), was an astounding success. The KPMG Clubhouse was packed to the brim with 120+ attendees, ranging from professionals in the pharmaceutical, biotech and medtech industry, to care providers and payers, to entrepreneurs, consultants and investors in the healthcare sector.

IGNite, short for Innovators Gathering Night, is a series of fireside chats with biotech and medtech innovators to find out what ignites their passion to innovate within their fields. Encouraged by the overwhelming responses we received in the two previous sessions featuring Dr. Murray Robinson and Mr. Abel Ang, we invited Ms. Jane Wang, CEO and Co-founder of Roceso Technologies to share with us what IGNites her passion in her medtech entrepreneurship journey. The chat was moderated by Mr. Chris L. Hardesty, Director of the KPMG’s Life Science Practice out of Singapore.

The Singapore Life Science Case Competition, the first of its kind, is a business case competition focused on the life sciences and pharmaceutical industries. Put together by Biotech Connection Singapore, L.E.K. Consulting and ESSEC Business School, this competition is open to all university students, postgraduates, researchers and biotech/medtech entrepreneurs.

In Singapore, there are over 400,000 people living with diabetes. Patients can develop complications, including cardiovascular disease, kidney disease, eye problems and foot ulcers. Diabetes cost Singapore more than S$1 billion in 2010 and is expected to soar to more than S$2.5 billion by 2050. Translational medicine is central to the goal of converting basic discoveries to diagnostic and therapeutic tools that can be harnessed to treat diseases and improve human health. In this panel discussion organized with the Eureka Institute of Translational Medicine on 7 August 2018, we focused on translational opportunities in diabetes.

Innovators Gathering Night (IGNite), is a series of fireside chats with biotech and medtech innovators to find out what ignites their passion to innovate within their fields. It is also a platform for current and future innovators to meet and network, and ignite conversations leading to collaborative opportunities. In our first IGNite event on 12 July 2018, jointly organised by BCS and A*START Central, we invited Dr. Murray Robinson, Chief Scientific Officer of MediSix Therapeutics, to join us for a fireside chat to find out what ignites his passion in the biotech field and how he embarked on his journey in innovation and entrepreneurship.

MARKETING LEAD

CONSULTING LEAD

CONSULTING LEAD

Translational medicine is central to the goal of converting basic discoveries to diagnostic and therapeutic tools that can be harnessed to treat disease and improve human health. The field of translational medicine is multidisciplinary, encompassing molecular medicine, intellectual property, financing, regulation, preclinical and clinical trial studies, among others. This is our first event of a series on translational medicine in collaboration with Eureka Institute of Translational Medicine.

There are many career paths in life science, each with its own set of challenges and rewards. In conjunction with International Women's Day, Biotech Connection Singapore (BCS) and Singapore Women in Science (SgWIS) jointly present our next panel discussion event - Paths to Excellence - Celebrating Journeys in Life Science.